SLC6A3 and Parkinson disease: In particular, LC3B was well-correlated with the severity of motor symptoms, AIs in the caudate and putamen in a semi-quantitative analysis of dopamine transporter imaging, and some conventional CSF biomarkers, supporting the hypothesis that ATG proteins represent potentially useful biomarkers of PD because they reflect the disease severity and contribute to an early diagnosis.